Rheographic indications for reduced cerebral vasoconstriction after oral magnesium medication in tetanic patients, a double-blind, placebo-controlled trial
Fehlinger, R.; Mielke, U.; Fauk, D.; Seidel, K.
Magnesium 5(2): 60-65
1986
ISSN/ISBN: 0252-1156 PMID: 3713254 Document Number: 4558
Volume and tonus oscillations of cerebral blood vessels are measurable with rheoencephalography. A lowered amplitude under resting conditions and an increased reactivity after hyperventilation (with pronounced and prolonged vasoconstriction) was found in tetanic patients, 360 mg Mg/day (as magnesium citrate tablets) was administered in 17 tetanic patients (A) and a placebo in 18 patients (B) in a double-blind, placebo-controlled trial. After 4 weeks the hyperventilation-induced vasoconstriction was reduced significantly within group A compared to group B.
Document emailed within 1 workday
Related Documents
Garg, R.K.; Nag, D.; Agrawal, A. 1995: A double blind placebo controlled trial of ginkgo biloba extract in acute cerebral ischaemia Journal of the Association of Physicians of India 43(11): 760-763Sangthawan, D.; Phungrassami, T.; Sinkitjarurnchai, W. 2013: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients Journal of the Medical Association of Thailand 96(1): 69-76
Harada, T.; Momoeda, M.; Terakawa, N.; Taketani, Y.; Hoshiai, H. 2011: Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial Fertility and Sterility 95(6): 1928-1931
Bede, O.; Surányi, A.; Pintér, K.; Szlávik, Mária.; Gyurkovits, Kálmán. 2003: Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: a randomized, placebo-controlled, double-blind study Magnesium Research 16(4): 262-270
Plewig, G.; Cunliffe, W.J.; Binder, N.; Höschen, K. 2009: Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase IIi trial Contraception 80(1): 25-33
Bieber, T.; Chosidow, O.; Bodsworth, N.; Tyring, S.; Hercogova, J.; Bloch, M.; Davis, M.; Lewis, M.; Boutolleau, D.; Attali, P.; Bisshop, F.R.; Bloch, M.T.; Bodworth, N.J.; Aster, V.; Asterova, J.; Hercogova, J.; Klimesova, R.; Krajsova, I.; Ben Slama, L.; Cambazard, F.; Chosidow, O.; Dubertret, L.; Granel, F.; Humbert, P.; Ortonne, J.P.; Rostain, G.; Ruer-Mulard, M.; Vaillant, L.; Beiber, T.; Degen, A.J.; Dörzapf, O.; von Hake, G.; Miller, A.; Naudts, I.; Steinert, M.; Stockfleth, E.; Weihe, J.; Wunderlich, U.; Jasieniak-Pinis, G.; Kazina, M.; Pawlaczyk-Strugala, E.; Placek, W.; Petryka, R.; Romanowski, L.; Dixon, C.J.; Lewis, M.; Sharma, R.; Archuleta, M.; Baker, D.A.; Cady, R.K.; Conant, M.A.; Crump, W.L.; Davis, M.G.; Dunlap, F.E.; Lee 2014: Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial Journal of Drugs in Dermatology: Jdd 13(7): 791-798
Mease, P.J.; Russell, I.J.; Arnold, L.M.; Florian, H.; Young, J.P.; Martin, S.A.; Sharma, U. 2008: A randomized, double-blind, placebo-controlled, phase IIi trial of pregabalin in the treatment of patients with fibromyalgia Journal of Rheumatology 35(3): 502-514
Feighner, J.; Targum, S.D.; Bennett, M.E.; Roberts, D.L.; Kensler, T.T.; D'Amico, M.F.; Hardy, S.A. 1998: A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression Journal of Clinical Psychiatry 59(5): 246-253
Bednarz, B.ła.; Jaxa-Chamiec, T.; Maciejewski, P.ł; Szpajer, M.ł; Janik, K.; Gniot, J.; Kawka-Urbanek, T.; Drozdowska, D.; Gessek, J.; Laskowski, H. 2005: Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMi pilot trial Kardiologia Polska 62(5): 421-427
Thienthong, S.; Krisanaprakornkit, W.; Taesiri, W.; Thaninsurat, N.; Utsahapanich, S.; Klaichanad, C. 2004: Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial Journal of the Medical Association of Thailand 87(1): 24-32
Shehata, N.A.A. 2016: RETRACTED: Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial European Journal of Obstetrics Gynecology and Reproductive Biology 198: 100-104
Bose, K. 1999: The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial Methods and Findings in Experimental and Clinical Pharmacology 21(3): 209-213
Cheechareoan, S.; Pathanawiriyasirikul, T.; Manmee, C.; Janpol, K. 2016: Efficacy of Plai Cream in Adult Patients with Muscle Strain: a Randomized, Double-Blind, Placebo-Controlled Trial Journal of the Medical Association of Thailand 99(Suppl 2): S147-S152
Tielemans, C.; Gastaldello, K.; Husson, C.; Marchant, A.; Delville, J.P.; Vanherweghem, J.L.; Goldman, M. 1999: Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled study Clinical Nephrology 51(3): 153-160
Sadoul, P. 1983: Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients European Journal of Respiratory Diseases. Supplement 126: 357-361
Percheron, Gëlle.; Hogrel, J-Yves.; Denot-Ledunois, Sà.; Fayet, G.; Forette, Fçoise.; Baulieu, E-Emile.; Fardeau, M.; Marini, J-François. 2003: Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial Archives of Internal Medicine 163(6): 720-727
Huang, F.; Zhang, J.; Zheng, Y.; Xu, J.-h.; Li, X.-f.; Wu, H.-x.; Chen, Z.-w.; Zhao, Z.; Zhang, Y.-m. 2011: A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis Zhonghua Nei Ke Za Zhi 50(12): 1043-1047
Scaglione, F.; Coduri, M.; Nebuloni, R.; Fraschini, F. 1983: Activity and tolerability of domifen bromide in patients affected by acute infectious dental diseases: a double-blind placebo-controlled trial International Journal of Clinical Pharmacology Research 3(5): 357-361
De Kam, P.-J.; van Kuijk, J.; Lillin, O.; Post, T.; Thomsen, T. 2014: The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial Clinical Drug Investigation 34(6): 413-420
Mantero, J.C.; Kishore, N.; Ziemek, J.; Stifano, G.; Zammitti, C.; Khanna, D.; Gordon, J.K.; Spiera, R.; Zhang, Y.; Simms, R.W.; Lafyatis, R. 2018: Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. a phase I/Ii biomarker trial Clinical and Experimental Rheumatology 36 Suppl 113(4): 146-149